These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 613561)
61. [Competitive inhibitors of angiotensin II]. Chamontin B; Salvador M; Guittard J Therapie; 1980; 35(5):637-40. PubMed ID: 7209861 [No Abstract] [Full Text] [Related]
62. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
63. The inhibition of rat renin in sodium depleted and renal hypertensive rats. Comparison of purified antibodies or Fab fragments against mouse submaxillary renin with SQ 20881, and the effect on blood pressure homeostasis. Lykkegård S Scand J Urol Nephrol Suppl; 1984; 79():17-22. PubMed ID: 6206557 [TBL] [Abstract][Full Text] [Related]
64. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension]. Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868 [No Abstract] [Full Text] [Related]
66. [Treatment of the hypertensive crisis by blocking the renin-angiotensin system (author's transl)]. Wambach G; Kaufmann W MMW Munch Med Wochenschr; 1982 Jul; 124(27):638-40. PubMed ID: 6810156 [No Abstract] [Full Text] [Related]
67. [Clinical pharacology of the new antihypertensive drugs: renin-angiotensin system antagonists, recent vasodilators and dopaminergic agonists]. Andréjak M; Hardin JM; Makdassi R; Bataille P; Gheerbrant JD; Fournier A Rev Prat; 1979 Dec; 29(57):4385-93. PubMed ID: 232771 [No Abstract] [Full Text] [Related]
69. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients]. Bönner G; Lang R; Hummerich W; Helber A; Meurer KA; Wambach G; Kaufmann W Med Welt; 1980 Sep; 31(38):1362, 1363-5. PubMed ID: 7001167 [No Abstract] [Full Text] [Related]
70. Intrarenal role of angiotensin II and [des-Asp1]angiotensin II. Hall JE; Coleman TG; Guyton AC; Balfe JW; Salgado HC Am J Physiol; 1979 Mar; 236(3):F252-9. PubMed ID: 426067 [No Abstract] [Full Text] [Related]
71. Comparative effects of teprotide and captopril. Ruddy MC Hypertension; 1981; 3(2):277-8. PubMed ID: 6163703 [No Abstract] [Full Text] [Related]
72. The second Volhard Lecture: The use of blocking agents to define the functions of the renin--angiotensin system. Davis JO Clin Sci Mol Med Suppl; 1975 Jun; 2():3s-14s. PubMed ID: 802643 [No Abstract] [Full Text] [Related]
73. Aldosterone response to angiotensin blockade in the conscious sodium-depleted rabbit. Rowe BP; Davis JO; Freeman RH; Stephens GA; DeForrest JM; Seymour AA; Williams GM Proc Soc Exp Biol Med; 1980 Jan; 163(1):120-5. PubMed ID: 7352135 [No Abstract] [Full Text] [Related]
74. Intracerebroventricular infusion of angiotensin II inhibits aldosterone secretion. Brooks VL; Malvin RL Am J Physiol; 1980 Dec; 239(6):E447-53. PubMed ID: 6160772 [No Abstract] [Full Text] [Related]
75. The role of hormones in congestive heart failure: new frontiers in therapy? Turini GA; Brunner HR Clin Sci (Lond); 1982 Oct; 63(4):333-8. PubMed ID: 6179686 [No Abstract] [Full Text] [Related]
76. Clinical use of angiotensin blocking agents. Case DB N Y State J Med; 1977 Nov; 77(13):2100-4. PubMed ID: 200867 [No Abstract] [Full Text] [Related]
77. Effects of SQ 20,881 on the intact kidney of dogs with two-kidney, one clip hypertension. Masaki Z; Ferrario CM; Bumpus FM Hypertension; 1980; 2(5):649-56. PubMed ID: 6158479 [No Abstract] [Full Text] [Related]
78. Angiotensin-dependent hypertension--potential pitfalls in definition. Williams GH N Engl J Med; 1977 Mar; 296(12):684-5. PubMed ID: 190538 [No Abstract] [Full Text] [Related]